ClinicalTrials.gov record
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
ClinicalTrials.gov ID: NCT00986154
Public ClinicalTrials.gov record NCT00986154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
Study identification
- NCT ID
- NCT00986154
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 8,292 participants
Conditions and interventions
Conditions
Interventions
- edoxaban tosylate(DU-176b) Drug
- low molecular weight heparin/unfractionated heparin Drug
- warfarin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Mar 31, 2013
- Completion
- Mar 31, 2013
- Last update posted
- Mar 4, 2019
2009 – 2013
United States locations
- U.S. sites
- 82
- U.S. states
- 25
- U.S. cities
- 74
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 7103 | Mobile | Alabama | 36608 | — |
| Investigational Site 7132 | Montgomery | Alabama | 36116 | — |
| Investigational Site 7126 | Phoenix | Arizona | 85006 | — |
| Investigational Site 7139 | Little Rock | Arkansas | 72205 | — |
| Investigational Site 1070 | Anaheim | California | 92801 | — |
| Investigational Site 7125 | Los Alamitos | California | 90720 | — |
| Investigational Site 1093 | Monterey | California | 93940 | — |
| Investigational Site 1069 | Palm Springs | California | 92262 | — |
| Investigational Site 7150 | San Diego | California | 92123 | — |
| Investigational Site 1089 | Vista | California | 92083 | — |
| Investigational Site 1012 | Aurora | Colorado | 80012 | — |
| Investigational Site 1013 | Boulder | Colorado | 80303 | — |
| Investigational Site 1017 | Denver | Colorado | 80218 | — |
| Investigational Site 1018 | Lakewood | Colorado | 80228 | — |
| Investigational Site 1019 | Littleton | Colorado | 80120-4413 | — |
| Investigational Site 1022 | Thornton | Colorado | 80260 | — |
| Investigational Site 1023 | Thornton | Colorado | 80260 | — |
| Not listed | Brandon | Florida | — | — |
| Investigational Site 1071 | Clearwater | Florida | 33756 | — |
| Investigational Site 7117 | Fort Myers | Florida | 33907 | — |
| Investigational Site 7106 | Gainesville | Florida | 32605 | — |
| Investigational Site 1005 | Ocoee | Florida | 34761 | — |
| Investigational Site 1006 | Orlando | Florida | 32806 | — |
| Investigational Site 7144 | Sarasota | Florida | 34232 | — |
| Investigational Site 7127 | St. Petersburg | Florida | 33707 | — |
| Investigational Site 1007 | Winter Park | Florida | 32789 | — |
| Investigational Site 7104 | Albany | Georgia | 31701 | — |
| Investigational Site 1095 | Columbus | Georgia | 31904 | — |
| Investigational Site 1080 | Jonesboro | Georgia | 30236 | — |
| Investigational Site 7146 | Savannah | Georgia | 31419 | — |
| Investigational Site 1098 | Park Ridge | Illinois | 60068 | — |
| Not listed | Carmel | Indiana | — | — |
| Investigational Site 7115 | Paducah | Kentucky | 42003 | — |
| Investigational Site 1065 | Covington | Louisiana | 70433 | — |
| Investigational Site 1068 | Baltimore | Maryland | 21215 | — |
| Investigational Site 1037 | Westminster | Maryland | 21157 | — |
| Investigational Site 1038 | Westminster | Maryland | 21157 | — |
| Investigational Site 7133 | Kansas City | Missouri | 64128 | — |
| Investigational Site 7147 | Butte | Montana | 59701 | — |
| Investigational Site 1039 | Las Vegas | Nevada | 89169 | — |
| Investigational Site 7143 | Rochester | New York | 14642 | — |
| Investigational Site 7135 | Durham | North Carolina | 27710 | — |
| Investigational Site 7145 | Statesville | North Carolina | 28625 | — |
| Investigational Site 7138 | Maumee | Ohio | 43537 | — |
| Investigational Site 7122 | Toledo | Ohio | 43606 | — |
| Investigational Site 7152 | Bend | Oregon | 97701 | — |
| Not listed | Portland | Oregon | — | — |
| Investigational Site 1004 | Camp Hill | Pennsylvania | 17011 | — |
| Investigational Site 7109 | Ephrata | Pennsylvania | 17522 | — |
| Investigational Site 1049 | Kingston | Pennsylvania | 18704 | — |
| Investigational Site 7109 | Lancaster | Pennsylvania | 17602 | — |
| Investigational Site 7154 | Sellersville | Pennsylvania | — | — |
| Investigational Site 7128 | Uniontown | Pennsylvania | — | — |
| Investigational Site 1031 | Easley | South Carolina | 29640 | — |
| Investigational Site 1032 | Greenville | South Carolina | 29605 | — |
| Investigational Site 1034 | Greenville | South Carolina | 29605 | — |
| Investigational Site 1033 | Greenville | South Carolina | 29615 | — |
| Investigational Site 1035 | Seneca | South Carolina | 29672 | — |
| Investigational Site 1036 | Spartanburg | South Carolina | 29307 | — |
| Investigational Site 1009 | Arlington | Texas | 76014-2084 | — |
| Investigational Site 1050 | Dallas | Texas | — | — |
| Investigational Site 1047 | Fort Worth | Texas | 76104 | — |
| Investigational Site 7105 | Fort Worth | Texas | 76109 | — |
| Investigational Site 1048 | Fort Worth | Texas | 76132 | — |
| Investigational Site 1059 | Midland | Texas | — | — |
| Investigational Site 1040 | New Braunfels | Texas | 78130 | — |
| Investigational Site 1041 | Odessa | Texas | — | — |
| Investigational Site 1002 | San Antonio | Texas | 78229 | — |
| Investigational Site 1058 | Sugar Land | Texas | — | — |
| Investigational Site 1042 | Tyler | Texas | — | — |
| Investigational Site 1008 | Waco | Texas | — | — |
| Investigational Site 7123 | Salt Lake City | Utah | — | — |
| Investigational Site 1003 | Fredericksburg | Virginia | — | — |
| Investigational Site 1025 | Newport News | Virginia | — | — |
| Investigational Site 1024 | Norfolk | Virginia | — | — |
| Investigational Site 1066 | Randallstown | Virginia | — | — |
| Investigational Site 1030 | Virginia Beach | Virginia | — | — |
| Investigational Site 7120 | Seattle | Washington | — | — |
| Investigational Site 1076 | Tacoma | Washington | — | — |
| Investigational Site 1053 | Vancouver | Washington | — | — |
| Investigational Site 1056 | Vancouver | Washington | — | — |
| Investigational Site 1057 | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 372 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00986154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00986154 live on ClinicalTrials.gov.